Jane Street Group, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

A detailed history of Jane Street Group, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 116,344 shares of CPRX stock, worth $2.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,344

Previous 63,355 83.64%

Holding current value

$2.78 Million

Previous $1.01 Million 78.59%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$14.68 - $16.92 $777,878 - $896,573	52,989 Added 83.64%	116,344 $1.8 Million
Q1 2024 May 15, 2024	SELL	$13.18 - $17.11 $383,893 - $498,362	-29,127 Reduced 31.49%	63,355 $1.01 Million
Q4 2023 Feb 14, 2024	SELL	$11.78 - $17.29 $999,356 - $1.47 Million	-84,835 Reduced 47.84%	92,482 $1.55 Million
Q3 2023 Nov 14, 2023	BUY	$11.69 - $15.02 $1 Million - $1.29 Million	85,911 Added 93.99%	177,317 $2.07 Million
Q2 2023 Aug 14, 2023	SELL	$11.5 - $18.08 $127,213 - $200,000	-11,062 Reduced 10.8%	91,406 $1.23 Million
Q1 2023 May 15, 2023	BUY	$14.34 - $21.05 $848,512 - $1.25 Million	59,171 Added 136.66%	102,468 $1.7 Million
Q4 2022 Feb 14, 2023	BUY	$12.25 - $19.5 $369,055 - $587,476	30,127 Added 228.75%	43,297 $805,000
Q3 2022 Nov 14, 2022	SELL	$7.06 - $15.52 $77,483 - $170,332	-10,975 Reduced 45.45%	13,170 $169,000
Q2 2022 Aug 16, 2022	SELL	$6.23 - $8.57 $318,508 - $438,141	-51,125 Reduced 67.92%	24,145 $169,000
Q1 2022 May 17, 2022	BUY	$5.31 - $8.31 $306,052 - $478,963	57,637 Added 326.87%	75,270 $624,000
Q4 2021 Feb 15, 2022	SELL	$5.21 - $7.45 $40,070 - $57,297	-7,691 Reduced 30.37%	17,633 $119,000
Q3 2021 Nov 16, 2021	BUY	$4.85 - $6.04 $20,913 - $26,044	4,312 Added 20.52%	25,324 $134,000
Q2 2021 Aug 16, 2021	BUY	$4.29 - $6.05 $90,141 - $127,122	21,012 New	21,012 $121,000
Q1 2021 May 18, 2021	SELL	$3.45 - $4.69 $112,656 - $153,147	-32,654 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$2.97 - $3.83 $392,182 - $505,743	-132,048 Reduced 80.17%	32,654 $109,000
Q3 2020 Nov 17, 2020	BUY	$2.97 - $5.08 $447,700 - $765,764	150,741 Added 1079.73%	164,702 $489,000
Q2 2020 Aug 17, 2020	BUY	$3.48 - $5.05 $48,584 - $70,503	13,961 New	13,961 $65,000
Q4 2019 Feb 14, 2020	SELL	$3.67 - $5.7 $90,927 - $141,223	-24,776 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.89 - $7.43 $96,378 - $184,085	24,776 New	24,776 $132,000
Q1 2018 May 15, 2018	SELL	$2.39 - $4.01 $44,740 - $75,067	-18,720 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$2.51 - $4.4 $13,250 - $23,227	-5,279 Reduced 22.0%	18,720 $73,000
Q3 2017 Nov 14, 2017	BUY	$2.4 - $2.94 $57,597 - $70,557	23,999	23,999 $60,000

Others Institutions Holding CPRX

# of Institutions

305

Shares Held

98.1M

Call Options Held

29.2K

Put Options Held

20.5K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.46B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Catalyst Pharmaceuticals, Inc. Transaction History